Q4 2010

Source filing unavailable

Q4 2010 · —

Revenue

$12.94M

no prior Q4 2009 on file

Net Income

$4.69M

no prior Q4 2009 on file

EPS Diluted

$0.24

no prior Q4 2009 on file

Operating Incomederived$4,664,000—

Operating Cash Flowderived$7,017,000N/M

Same quarter

Metric	Q4 2010	Q4 2009derived from reported figures
Revenue	$12.94M	—
Net Income	$4.69M	—
EPS Diluted	$0.24	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR